Public Willingness and Determinants of COVID-19 Vaccination at the Initial Stage of Mass Vaccination in China

Author:

Zhao Yi-Miao,Liu Lin,Sun JieORCID,Yan Wei,Yuan Kai,Zheng Yong-Bo,Lu Zheng-An,Liu Lin,Ni Shu-Yu,Su Si-Zhen,Zhu Xi-Mei,Zeng NaORCID,Gong Yi-Miao,Wu Ping,Ran Mao-ShengORCID,Leng Yue,Shi Jie,Shi Le,Lu Lin,Bao Yan-Ping

Abstract

The present study assessed the willingness of the general population to receive COVID-19 vaccines and identified factors that influence vaccine hesitancy and resistance. A national online survey was conducted from 29 January 2021 to 26 April 2021 in China. Multinomial logistic regression analyses were conducted to identify factors that influence vaccine hesitancy and resistance. Of the 34,041 participants surveyed, 18,810 (55.3%) were willing to get vaccinated, 13,736 (40.3%) were hesitant, and 1495 (4.4%) were resistant. Rates of vaccine acceptance increased over time, with geographical discrepancies in vaccine hesitancy and resistance between provinces in China. Vaccine safety was the greatest concern expressed by most participants (24,461 [71.9%]), and the major reason for participants’ refusing vaccination (974 [65.2%]). Government agencies (23,131 [68.0%]) and social media (20,967 [61.6%]) were the main sources of COVID-19 vaccine information. Compared with vaccination acceptance, female, young and middle-aged, high income, and perceived low-risk of infection were associated with vaccine hesitancy. Histories of allergic reactions to other vaccines and depression symptoms were related to vaccine resistance. Common factors that influenced vaccine hesitancy and resistance were residing in cities and perceiving less protection with vaccines than with other protective measures. The results indicate that the rate of vaccine resistance is relatively low, but vaccine hesitancy is common. Individuals who are female, young and middle-aged, with a high income, and residing in cities are more likely to be hesitant for vaccination and should be the target populations for vaccination campaigns. Specific vaccine messaging from the government and social media could alleviate public concerns about vaccine safety and efficacy.

Funder

National Key Research and Development Program of China

National Natural Science Foundation of China

Publisher

MDPI AG

Subject

Pharmacology (medical),Infectious Diseases,Drug Discovery,Pharmacology,Immunology

Reference37 articles.

1. World Health Organization Coronavirus (COVID-19) Dashboardhttps://covid19.who.int/

2. WHO COVID-19 Vaccine Tracker and Landscapehttps://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines

3. World Health Organization Emergency Use Listing (EUL) of COVID-19 Vaccineshttps://www.who.int/teams/regulation-prequalification/eul/covid-19

4. Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment

5. COVID-19 vaccine acceptance and hesitancy in low- and middle-income countries

全球学者库

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"全球学者库"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前全球学者库共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2023 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3